乳腺癌指南建议中的差异,尽管科克莱恩系统性审查的结论类似
Zhigang Zhang1,2,3, Jie Cheng2,4, Jialu Hou4
1Intensive Care Units, Lanzhou University First Affiliated Hospital, Lanzhou, China.
Journal of evidence-based medicine
|March 9, 2024
概括
关于乳腺癌的科克莱恩系统审查 (CSR) 在指导方针中被引用,但建议往往与审查结论相冲突,并且在指导方针之间不一致.
科学领域:
- 在瘤学瘤学.
- 基于证据的医学 基于证据的医学
- 健康科学 卫生科学 卫生科学
背景情况:
- 临床实践指南对于治疗乳腺癌至关重要.
- 柯克伦系统审查 (CSR) 是指导方针的关键证据来源.
- 了解企业社会责任如何融入乳腺癌指南至关重要.
研究的目的:
- 分析乳腺癌管理指南中CSR的引用模式.
- 评估CSR结论与指导方针建议之间的一致性.
- 评估不同乳腺癌指南中建议的一致性.
主要方法:
- 系统搜索乳腺癌CSR在科克伦图书馆 (开始到2023年11月).
- 识别和分析引用这些CSR的指导方针.
- 检查引用频率,CSR结论和建议之间的关系,以及指南间的一致性.
主要成果:
- 分析了64个企业企业责任和228条指导方针.
- 企业企业责任在每条指南中平均被引用5.91次.
- 38.36%的引用条目显示不相关或不一致的建议.
- 只有15.15%的基于主题的建议组在指南中完全一致.
结论:
- 乳腺癌指南引用CSR,但有明显的不一致性.
- 准则建议经常与企业社会责任结论有所不同.
- 在不同指南中对类似主题的建议存在显著的变化.
相关概念视频
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Methods of Documentation V: CBE
902
Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
902
Hazard Ratio
121
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
121
Comparing the Survival Analysis of Two or More Groups
186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K


